Meeder Advisory Services Inc. purchased a new position in shares of UiPath, Inc. (NYSE:PATH – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 10,233 shares of the company’s stock, valued at approximately $105,000.
Other hedge funds also recently modified their holdings of the company. Versant Capital Management Inc increased its stake in shares of UiPath by 198.6% during the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company’s stock worth $31,000 after purchasing an additional 1,970 shares during the last quarter. CX Institutional acquired a new position in UiPath in the 1st quarter valued at $36,000. True Wealth Design LLC grew its stake in UiPath by 18.4% in the 4th quarter. True Wealth Design LLC now owns 5,163 shares of the company’s stock valued at $66,000 after buying an additional 801 shares during the last quarter. MRP Capital Investments LLC acquired a new position in UiPath in the 1st quarter valued at $82,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in UiPath in the 4th quarter worth $102,000. Institutional investors and hedge funds own 62.50% of the company’s stock.
Insider Buying and Selling at UiPath
In related news, CFO Ashim Gupta sold 56,322 shares of the stock in a transaction on Wednesday, July 2nd. The shares were sold at an average price of $12.72, for a total transaction of $716,415.84. Following the completion of the transaction, the chief financial officer owned 859,991 shares in the company, valued at approximately $10,939,085.52. This represents a 6.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Daniel Dines sold 45,000 shares of the stock in a transaction on Wednesday, July 16th. The stock was sold at an average price of $12.43, for a total transaction of $559,350.00. Following the transaction, the chief executive officer owned 5,058,376 shares of the company’s stock, valued at $62,875,613.68. The trade was a 0.88% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 831,310 shares of company stock valued at $10,428,922 in the last 90 days. 23.19% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on PATH
UiPath Stock Down 5.4%
Shares of PATH stock opened at $11.11 on Friday. The firm has a fifty day moving average of $12.63 and a 200-day moving average of $12.38. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $15.93. The company has a market capitalization of $5.94 billion, a price-to-earnings ratio of -92.58, a P/E/G ratio of 15.39 and a beta of 1.04.
UiPath (NYSE:PATH – Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The company had revenue of $356.62 million during the quarter, compared to the consensus estimate of $332.17 million. During the same quarter in the prior year, the firm earned $0.13 earnings per share. The firm’s revenue was up 6.4% compared to the same quarter last year. On average, equities analysts expect that UiPath, Inc. will post -0.17 EPS for the current year.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Further Reading
- Five stocks we like better than UiPath
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MarketBeat Week in Review – 07/28 – 08/01
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Will Hims & Hers Fall Along With Novo Nordisk?
- What is a penny stock? A comprehensive guide
- Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.